Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain-Reference-Cited by-同舟云学术

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain

Published:2023-07-11 Issue:14 Volume:17 Page:13121-13136
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Nong Jia¹,Glassman Patrick M.¹²^ORCID,Myerson Jacob W.¹,Zuluaga-Ramirez Viviana³,Rodriguez-Garcia Alba⁴⁵,Mukalel Alvin⁶,Omo-Lamai Serena⁷,Walsh Landis R.¹,Zamora Marco E.¹⁸^ORCID,Gong Xijing¹⁷,Wang Zhicheng¹,Bhamidipati Kartik¹,Kiseleva Raisa Y.¹,Villa Carlos H.¹,Greineder Colin Fred¹^ORCID,Kasner Scott E.⁹,Weissman Drew¹⁰^ORCID,Mitchell Michael J.⁶¹¹¹²¹³¹⁴^ORCID,Muro Silvia¹⁵¹⁶¹⁷,Persidsky Yuri³¹⁸,Brenner Jacob Samuel¹⁷^ORCID,Muzykantov Vladimir R.¹,Marcos-Contreras Oscar A.¹⁹

Affiliation:

1. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

2. Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, United States

3. Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, United States

4. Department of Pathology and Laboratory Medicine, Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

5. Center for Cellular Immunotherapies, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

6. Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

7. Division of Pulmonary Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

8. School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pennsylvania 19104, United States

9. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

10. Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

11. Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

12. Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

13. Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

14. Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

15. Institute for Bioengineering of Catalonia (IBEC), Barcelona, 08028, Spain

16. Institute of Catalonia for Research and Advanced Studies (ICREA), Barcelona, 08010, Spain

17. Institute for Bioscience and Biotechnology (IBBR), College Park, Maryland 20850, United States

18. Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, United States

Funder

National Center for Advancing Translational Sciences

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

American Heart Association

American Cancer Society

Burroughs Wellcome Fund

Cardiovascular Institute,University of Pennsylvania

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.2c08275

Reference94 articles.

1. Getting into the Brain

2. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery

3. Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors

4. Surface chemistry governs cellular tropism of nanoparticles in the brain

5. Core-Cross-Linked Nanoparticles Reduce Neuroinflammation and Improve Outcome in a Mouse Model of Traumatic Brain Injury

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Cellular Models to Support Preclinical Studies on ICAM-1-Targeted Drug Delivery;Journal of Drug Delivery Science and Technology;2024-09

2. Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke;Molecular Therapy;2024-05

3. Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting;Nano Letters;2024-04-10

4. Emerging strategies for nanomedicine in autoimmunity;Advanced Drug Delivery Reviews;2024-04

5. Blood–Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma;ACS Nano;2024-03-18